医学
免疫检查点
癌症免疫疗法
肿瘤微环境
抗原
接种疫苗
背向效应
黑色素瘤
肿瘤抗原
树突状细胞
无容量
癌症
佐剂
CD8型
彭布罗利珠单抗
作者
Yingying Hu,Lin Lın,Zhaopei Guo,Jie Chen,Atsushi Maruyama,Huayu Tian,Xuesi Chen
标识
DOI:10.1016/j.cclet.2020.12.055
摘要
Abstract Despite of the promising achievements of immune checkpoints blockade therapy (ICB) in the clinic, which was often limited by low objective responses and severe side effects. Herein, we explored a synergistic strategy to combine in situ vaccination and gene-mediated anti-PD therapy, which was generated by unmethylated cytosine-phosphate-guanine (CpG) and pshPD-L1 gene co-delivery. PEI worked as the delivery carrier to co-deliver the CpG and pshPD-L1 genes, the formed PDC (PEI/DNA/CpG) nanoparticles were further shielded by aldehyde modified polyethylene glycol (OHC-PEG-CHO) via pH responsive Schiff base reaction for OHC-PEG-CHO-PEI/DNA/CpG nanoparticles (P(PDC) NPs) preparation. All steps could be finished within 30 min. Such simple nanoparticles achieved the synergistic antitumor efficacy in B16F10 tumor-bearing mice, and the amplified T cell responses, together with enhanced NK cells infiltration were observed after the combined treatments. In addition, the pH responsive delivery system reduced the side effects triggered by anti-PD therapy. The facile and effective combination strategy we presented here might provide a novel treatment for tumor inhibition.
科研通智能强力驱动
Strongly Powered by AbleSci AI